Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Drug Development Company

Drug Development Company Newsletter

JPMorgan Cuts Sarepta (SRPT) PT, Keeps Overweight Rating 16 Jul 2025 17:29 GMT
… ) is a medical research and drug development company focused on developing precision genetic …
Magic Mushrooms could lengthen your lifespan 16 Jul 2025 17:01 GMT
… Canadian clinical-stage natural psychedelic drug development company, previously stressed to Fox News …
Qualigen Granted New Patents Covering 25 Countries 16 Jul 2025 12:00 GMT
… strengthens our position as a drug development company. By assuring such strong coverage …
The key to living longer could be tied to a surprising substance, study suggests 16 Jul 2025 09:49 GMT
… , a clinical-stage natural psychedelic drug development company in Canada, has emphasized the …
Senhwa Biosciences announces first patient dosed in NCI-sponsored pilot study of Pidnarulex (CX-5461) pharmacodynamics in patients with advanced solid tumors 16 Jul 2025 03:44 GMT
… , Inc. (TPEx: 6492), a new drug development company focusing on first-in-class …
AI robotic drug development company Persist AI raises $12 million 22 May 2025 03:46 GMT
Drug development company lands £1.1m boost marking “significant milestone” 11 Apr 2025 11:11 GMT
A Newcastle-based drug development company has secured a £1.1m …
AI Drug Development Company Receives $600M in First Round Financing 02 Apr 2025 16:10 GMT
Isomorphic Labs, an AI-first drug design and development company, announced it has raised $600 Million in its first external funding round. The financing round is led by Thrive Capital, with participation from GV, and follow-on capital from existing …
EXCL: DHSC-owned drug development company to close 06 Mar 2025 23:46 GMT
Porton Biopharma, a drug development and production company owned by the Department of Health and Social Care, will be shut down, CSW can reveal. The firm was part of Public Health England (the predecessor to the UK Health Security Agency) until 2015, …
STAT+: Recursion, the AI drug development company, cuts more jobs after finalizing Exscientia merger 27 Nov 2024 03:16 GMT

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS